Cathie Wood Recursion Pharmaceuticals, Inc. Transaction History

Ark Investment Management LLC

$14.2 Billion
Q3 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 33,545,499 shares of RXRX stock, worth $139 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

33,545,499

Previous 32,988,631 1.69%

Holding current value

$139 Million

Previous $167 Million 1.93%

% of portfolio

1.15%

Previous 1.38%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$4.52 - $6.54 $2.52 Million - $3.64 Million	556,868 Added 1.69%	33,545,499 $164 Million
Q2 2025 Jul 30, 2025	SELL	$3.97 - $5.84 $7.25 Million - $10.7 Million	-1,826,871 Reduced 5.25%	32,988,631 $167 Million
Q1 2025 May 07, 2025	BUY	$5.29 - $10.87 $13.1 Million - $26.8 Million	2,469,104 Added 7.63%	34,815,502 $184 Million
Q4 2024 Feb 04, 2025	SELL	$5.7 - $8.27 $2.41 Million - $3.5 Million	-422,788 Reduced 1.29%	32,346,398 $219 Million
Q3 2024 Oct 31, 2024	BUY	$5.92 - $8.6 $27.4 Million - $39.8 Million	4,626,268 Added 16.44%	32,769,186 $216 Million

Q2 2024 Jul 26, 2024	BUY	$7.35 - $10.05 $26.1 Million - $35.7 Million	3,555,357 Added 14.46%	28,142,918 $211 Million
Q1 2024 Apr 18, 2024	BUY	$9.13 - $15.52 $35.9 Million - $61 Million	3,933,274 Added 19.04%	24,587,561 $245 Million
Q4 2023 Jan 17, 2024	BUY	$5.09 - $10.79 $70.1 Million - $149 Million	13,777,689 Added 200.36%	20,654,287 $204 Million
Q3 2023 Oct 18, 2023	BUY	$6.59 - $15.86 $14.1 Million - $33.9 Million	2,138,081 Added 45.12%	6,876,598 $52.6 Million
Q2 2023 Jul 10, 2023	BUY	$4.56 - $9.94 $5.3 Million - $11.5 Million	1,161,655 Added 32.48%	4,738,517 $35.4 Million
Q1 2023 Apr 17, 2023	BUY	$6.42 - $9.64 $3.06 Million - $4.6 Million	477,372 Added 15.4%	3,576,862 $23.9 Million
Q4 2022 Jan 24, 2023	SELL	$7.16 - $12.7 $1.86 Million - $3.31 Million	-260,321 Reduced 7.75%	3,099,490 $0
Q3 2022 Oct 17, 2022	BUY	$7.83 - $13.6 $4.92 Million - $8.54 Million	627,724 Added 22.98%	3,359,811 $35.7 Million
Q2 2022 Jul 11, 2022	SELL	$5.04 - $9.26 $479,183 - $880,403	-95,076 Reduced 3.36%	2,732,087 $16.7 Million
Q1 2022 Apr 19, 2022	BUY	$6.16 - $18.03 $3.67 Million - $10.7 Million	595,150 Added 26.66%	2,827,163 $20.2 Million
Q4 2021 Jan 28, 2022	SELL	$16.14 - $21.86 $5.84 Million - $7.91 Million	-361,823 Reduced 13.95%	2,232,013 $38.2 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $4.09 Million - $8.89 Million	215,161 Added 9.05%	2,593,836 $59.7 Million
Q2 2021 Aug 05, 2021	BUY	$18.0 - $37.42 $42.8 Million - $89 Million	2,378,675 New	2,378,675 $86.8 Million

Others Institutions Holding RXRX

# of Institutions

362

Shares Held

301M

Call Options Held

7.71M

Put Options Held

4.85M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $747M
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account